Article · 2012
Editor
Gal Bitan
Associate Professor, University of California, USA
About
As published by the journal they serve.
Gal Bitan completed his graduate studies in organic chemistry at the Hebrew University of Jerusalem, Israel. He is a co-inventor of patented methodologies for peptide cyclization, which formed the basis for creation of the biotechnology company Peptor, Inc. In his postdoctoral studies on protein misfolding and aggregation at Brigham and Women’s Hospital and Harvard Medical School, Dr. Bitan has made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer′s disease. He introduced the use of novel photochemical protein cross-linking techniques for investigation of amyloid β-protein assembly and discovered one of the earliest oligomers in the assembly cascade, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently an Associate Professor. His research focuses on novel therapeutic strategies for protein misfolding diseases, such as Alzheimer’s, Parkinson’s, and type-2 diabetes. In recognition of his achievements, Dr. Bitan received the Turken research award.
Qualifications
PhD
Journals they serve
The seats these journals name them in.
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2019
Biomarkers in brain-derived exosomes assist the diagnosis of neurodegenerative diseases
Article · 2019
Biomarkers in brain-derived exosomes assist the diagnosis of neurodegenerative diseases
Article · 2013
Molecular tweezers: Novel protein aggregation inhibitors show promise for treatment and prevention of amyloidoses
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
